Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial

W. F. Sindelar, T. J. Kinsella, P. W. Chen, T. F. DeLaney, J. E. Tepper, S. A. Rosenberg and E. Glatstein
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.

Thirty-five patients with surgically resected sarcomas of the retroperitoneum were enrolled in a prospective, randomized, clinical trial comparing 20-Gy intraoperative radiotherapy in combination with postoperative low-dose (35- to 40-Gy) external-beam radiotherapy with postoperative high-dose (50- to 55-Gy) external-beam radiotherapy alone. Chemotherapy with doxorubicin hydrochloride, cyclophosphamide (anhydrous), and methotrexate sodium was used for a portion of the trial. Fifteen patients who received intraoperative radiotherapy and 20 control patients were followed up for a minimum of 5 years (median follow-up, 8 years). Median survival times were similar for the group that received intraoperative radiotherapy (45 months) and the control group (52 months). There were no indications of benefit from adjunctive chemotherapy. The number of locoregional recurrences was significantly lower among those who received intraoperative radiotherapy (six of 15) than control patients (16 of 20). Patients who received intraoperative radiotherapy had fewer complications of disabling radiation-related enteritis (two of 15) than control patients (10 of 20), but radiation-related peripheral neuropathy was more frequent among those who received intraoperative radiotherapy (nine of 15) than among control patients (one of 20).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evidence-Based Recommendations for Local Therapy for Soft Tissue Sarcomas
Pisters et al.
JCO 2007;25:1003-1008.
ABSTRACT | FULL TEXT  

Complications Associated with Neoadjuvant Radiotherapy in the Multidisciplinary Treatment of Retroperitoneal Sarcomas
Caudle et al.
Ann. Surg. Oncol. 2007;14:577-582.
ABSTRACT | FULL TEXT  

Use of Tissue Expanders and Pre-operative External Beam Radiotherapy in the Treatment of Retroperitoneal Sarcoma
White et al.
Ann. Surg. Oncol. 2007;14:583-590.
ABSTRACT | FULL TEXT  

Long-Term Results of Two Prospective Trials of Preoperative External Beam Radiotherapy for Localized Intermediate- or High-Grade Retroperitoneal Soft Tissue Sarcoma
Pawlik et al.
Ann. Surg. Oncol. 2006;13:508-517.
ABSTRACT | FULL TEXT  

Surgery Combined With Intraoperative Brachytherapy in the Treatment of Retroperitoneal Sarcomas
Dziewirski et al.
Ann. Surg. Oncol. 2006;13:245-252.
ABSTRACT | FULL TEXT  

Soft-Tissue Sarcomas in Adults
Clark et al.
NEJM 2005;353:701-711.
FULL TEXT  

Phase I Trial of Preoperative Concurrent Doxorubicin and Radiation Therapy, Surgical Resection, and Intraoperative Electron-Beam Radiation Therapy for Patients With Localized Retroperitoneal Sarcoma
Pisters et al.
JCO 2003;21:3092-3097.
ABSTRACT | FULL TEXT  

Response to Neoadjuvant Chemotherapy Combined With Regional Hyperthermia Predicts Long-Term Survival for Adult Patients With Retroperitoneal and Visceral High-Risk Soft Tissue Sarcomas
Wendtner et al.
JCO 2002;20:3156-3164.
ABSTRACT | FULL TEXT  

Influence of Biologic Factors and Anatomic Site in Completely Resected Liposarcoma
Linehan et al.
JCO 2000;18:1637-1643.
ABSTRACT | FULL TEXT